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Background: Conventional methods of detecting Brucella spp. suffer from technical and biological complications. Besides, newly
characterized species of the genus Brucella could be neglected by previously designed polymerase chain reaction (PCR) tests. Therefore,
a more accurate PCR-based test seems to be imminently needed.
Materials and methods: Blood samples were collected from 39 patients diagnosed with brucellosis and 25 healthy controls. Multiple
sequence alignments (MSA) were performed on 500 Omp2-related protein and gene sequences. Thereafter, specific primers were
designed and synthesized for the regions with highest conservancy. The collected samples were assessed by PCR test. To overcome the
cross-reactivity issue, PCR thermal program was optimized regarding annealing time and temperature.
Results: The MSA results indicated that the N terminus region of the Omp2 protein (DNA 5’ end) is associated with highest conservancy.
Primers with highest specificity were designed and synthesized. A two-step PCR reaction was successfully designed and optimized. The
desirable bands were observed in clinical samples with high accuracy.
Conclusion: It should be pointed out that using a precisely designed primer pair would bring about early infection detection, more
success to detect all natural variants and higher cost-to-efficacy ratio in comparison to other detection methods.
Key words: Brucellosis, diagnosis, Omp2, primer design, multiple sequence alignment, PCR

1. Introduction
Brucellosis is a highly contagious zoonosis infection
caused by Brucella spp. which are gram-negative, aerobic,
nonsporulating, and coccobacillus bacteria. This infection
(also known as Malta fever) is common in human and some
animal species (1). More than 300 million cattle infections
(out of the 1.4 billion cattle population worldwide), as well
as more than 500,000 annual new human infections, are
estimated to be the global disease burden for brucellosis
(2). David Bruce was the first to identify the relationship
between these bacteria and the resulting disease in 1887.
During 1905, Themistocles Zammit discovered that
consumption and/or close contact to unsterilized milk
and meat of contaminated animals is the source of this
infection. The members of the genus Brucella are facultative
intracytoplasmic parasites traditionally consisting of 6
recognized species. Brucella melitensis, Brucella abortus,
Brucella suis, Brucella canis, Brucella ovis, and Brucella

neotomae are respectively responsible for pathogenesis
in goats and sheep, cows, pigs, dogs, sheep, and pack rat
midden (Neotoma cinerea). However, B. inopinata, B.
pinnipedialis, B. ceti, and B. microti are newly characterized
species of the genus Brucella isolated from human, aquatic
mammals, and common vole, respectively (3). The failure
of attempts to eradicate this disease and the absence of any
approved human vaccines underscores the significance of
this infection as an ongoing clinical issue.
Diagnostic approaches for identification of brucellosis
include microbiological, serological, and molecular
approaches. Analyzing blood, bone marrow, cerebrospinal
fluid, and synovial fluid (during fevers) samples along
with the screening of culture isolates are the common
ways of Brucella detection. Unfortunately, sample culture
and screening is not achievable in chronic infections.
World Health Organization (WHO) has described 5
standard serologic experiments to identify the Brucella
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infection. These experiments include: Rose Bengal, Seroagglutination or Wright, 2 Mercaptoethanol–Wright,
Complement Fixation, and Antiglobulin or Coombs–
Wright which are all dependent on different levels
of human immune responses against the pathogen.
Complexity of pathogenicity and chronic states along with
B. abortus and B. canis infection reduces the blood culturebased identification chances to 30%–50%. Long life cycles
(more than 30 days) of Brucella spp. make golden tests
inappropriate (4). Aforementioned serological tests with
65%–95% diagnostic accuracy not only are inappropriate
in endemic regions with high frequency of antibody
existence but also have cross-reactivity with other bacteria
(5). Different aspects of Brucella spp. genomes have
already been studied. Availability of DNA, RNA, and
ribosomal RNA (rRNA) of Brucella spp. in human blood
makes it amenable for molecular detection via PCR-based
methods. The DNA sequences of 43 kDa membrane
protein of B. aburtus (6) and 31 kDa BCSP31 of B. aburtus
and B. melitensis (7) were the first sequences employed
for Brucella spp. detection using PCR-based molecular
techniques. Various ribosomal DNA (rDNA) regions such
as 16S gene or fragments between 16S and 23S genes were
also analyzed with different PCR techniques (8–10).
Although molecular methods of Brucella spp.
detection have some advantages over conventional
microbiological and serological methods, low sensitivity
could be the only cause of their poor detection ability.
This could be the consequence of natural polymorphisms
or newly characterized species whose sequences were not
taken into account in PCR test design. Bioinformatics
approaches are now widely used in various fields of
biology (11–18). Using bioinformatics tools could be a
compelling approach to circumvent the sensitivity issues
of the molecular methods of Brucella spp. detection. In the
present study, we exploited bioinformatics tools to analyze
the sequences of Omp2 gene from Brucella spp. to identify
the regions with highest conservancy and design-specific
primers with highest convergence for Brucella Omp2 gene
sequences. To evaluate the applicability of the designed
PCR test, infected samples were collected from Hamedan
and Bahar cities and used for possible improved molecular
detection.
2. Materials and methods
2.1. Patients and specimens
Samples were collected from hospitalized patients with
brucellosis diagnosed by antibody raises (1/320-1/1280)
from Hamedan and Bahar cities. Overall, 29 blood
samples were obtained by venipuncture and used for
further studies. Top Bioscience genomic extraction kit
(Iran) was employed to extract DNA contents. Briefly, 200
µL of blood sample and 20 µL proteinase K were gently

mixed and centrifuged for 5 min at 400 g. The pellets were
resuspended in 200 µL of PBS. 200 µL of lysis buffer was
added into the solution and incubated at 20° C for 30
min. The solution was then treated by 200 µL of ice-cold
pure ethanol by gentle pipetting. The solution was later
centrifuged (MERCK, Germany) at 6000 rpm for 1 min
in DNA extraction kit columns (Top BioScience, Iran).
Washing and elusion buffers were added subsequently
after each centrifuge and microtube replacement. DNA
concentration in TAE buffer (BIOIDEA, Iran) was
determined with NanoDrop spectrophotometer (2000c,
Thermo Fisher Scientific, USA).
2.2. Conservancy analyses and Brucella-specific primer
design
The sequence of Omp2 gene and protein from Brucella
abortus was obtained from NCBI gene bank and protein
database at https://www.ncbi.nlm.nih.gov. The Omp2
DNA and protein sequences were used to perform
nucleotide and protein basic local alignment search tool
(BLAST) searches at https://blast.ncbi.nlm.nih.gov/Blast.
cgi. The BLAST searches were limited to the Brucella spp.
sequences. The number of target sequences to be returned
was set to 500 sequences. The sequences of Omp2 from
different Brucella species were aligned with MEGA
software (version 7) for both DNA and protein sequences.
The conserved regions of the Omp2 gene and protein were
recognized using alignment results. The BioEdit software
was employed to draw entropy plots of Omp2 DNA and
protein alignment results. Primers were designed by
Primer3 Online program (http://primer3.sourceforge.
net). Thermodynamic characteristics of the primers, such
as stability, dimer, or loop formation, were analyzed with
Allele ID software (version 6) and Gene Runner software
(version 3.05). Approved primer pairs were used to
perform primer BLAST search at https://www.ncbi.nlm.
nih.gov/tools/primer-blast/.
2.3. Preparation of internal control (IC)
A previously described set of primer pair was selected
to be employed as the IC gene. The primer is specific to
the chromosome X of Drosophila melanogaster (19).
The resulting PCR product was cloned into a common
TA vector. The Thermo Fisher Scientific TA cloning kit
was employed to perform the cloning. All procedures
were carried out according to the instructions of the
manufacturer. The final plasmid was transformed into
chemically competent E. coli bacteria. DNA sequencing
was finally used to confirm the procedure and the accuracy
of the cloned sequences. Standard plasmid extraction kit
(GeneAll Biotechnology, Korea) was employed to obtain
the cloned TA vectors according to the manufacturer’s
instructions. Nanodrop spectrophotometer (2000c,
Thermo Fisher Scientific, USA) was employed to calculate
the concentration of the extracted plasmids.
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2.4. PCR test setup
PCR tests were designed to set the best conditions of
reactions for IC, reference strain of Brucella abortus
(purchased from the reference laboratory of Iran and
the Pasteur Institute of Iran) and coreactions of IC and
reference sequence. Different optimization procedures
were performed to improve PCR conditions regarding the
temperatures and durations of each PCR step. PCR products
were analyzed by agarose gel electrophoresis (Invitrogen,
USA) along with 100 bp DNA Marker (Cinagen, Iran) in
TBE (Bio-Idea, Iran) buffered electrophoresis tank (Biorad,
USA). Results were visualized in a gel documentation
device (UVSAVE HD2, UVITEC, ENGLAND) after
staining with GelRed (BIOTUM, USA).
3. Results
3.1. Sequence analyses
The reference sequence of Brucella abortus Omp2 gene
was obtained under the NCBI ID of NC_006932.1. The
Omp2 gene is a 1098 nucleotide gene which is translated
into a 362 amino acids protein. The BLAST search results
lead to identification of 500 sequences with high sequence

similarity to Omp2 gene and protein. The BLAST search
results included sequences from all 10 Brucella spp.. The
alignment results for different Omp2 genes and proteins
showed that there is a highly conserved region at the N
terminus region of the Omp2 protein, while the rest of the
sequence is more variable. This region includes 100 amino
acids of the protein N terminus. These observations were
confirmed with the results of the Omp2 gene MSA. It has
been shown that initial 300 bp form the 5’ end of Omp2
gene (Figure 1) is the best fit for the primer design analyses.
Moreover, our entropy plot calculations have confirmed
the results of protein and DNA MSAs (Figure 2).
3.2. Primer design
The analyses for primer design require 2 pairs of primers
for IC and Omp2 genes. The primer sequences for the
genes are listed in Table 1. The primer BLAST analyses
we performed demonstrated no cross-reactions between
Omp2 and other Brucella genes as well as human; and
their specificity was confirmed for Omp2a and 2b.
3.3. Gene cloning and PCR reaction setup
The sequence of IC was successfully inserted into TA
vector. The sequencing results confirmed the accuracy

Figure 1. The sequence of the conserved region of the Omp2 gene.

Figure 2. The entropy plot of Omp2 gene sequences derived from multiple sequence alignment (MSA) results. The first 1100 positions
are the sequences with lowest diversity. This region includes the 300 base pair (bp) of the 5’ end of Omp2 gene. The existing gaps in the
MSA results extended the length of the plot.
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of the cloning process. The concentrations of extracted
DNA was 100 and 40 ng/µL for IC containing TA vector
and genomic DNA extracted from clinical samples
and reference strain of Brucella. The accuracy of PCR
amplification was confirmed for Brucella using standard
bacteria. The volumes of each PCR ingredient is listed
for single and coreaction PCR conditions in Table 2. The
initial PCR program for single and coreaction PCRs was
as follow:
{[Initial denaturation: 95 °C for 5 min][35 cycles of
(denaturation: 95 °C for 20 s, annealing: 60 °C for 30 s,
extension: 72 °C for 30 s)][Final extension: 72 °C for 7
min]}
This reaction condition could optimally amplify the
single PCRs for the IC and reference Brucella genome.
However, in the case of samples from patients, extra settings
were needed. Although the specific band was observed (233
bp) at annealing temperature of 60 °C, unspecific bands
were also traced in the vicinity of coreactions for clinical
samples. Increasing number of reaction cycles into 40 and
Touchdown PCR with 200 and 140 nM concentrations of
Brucella primers could not eliminate nonspecific bands.
Finally, two-step PCR was used based on following PCR
protocol and thermal program:
{[Initial denaturation: 95 °C for 5 min] [10 cycles of
(denaturation: 95 °C for 45 s, annealing: 57 °C for 30 s,
extension: 72 °C for 10 s)] [Fin.Ext:72 °C for 2 min]}c{25
cycles of (denaturation: 95 °C for 25 s, annealing: 60 °C for

30 s, extension: 72 °C for 10 s)] [Final extension: 72°C for
2 min]}
The two-step program was successful at amplifying
both IC and Brucella Omp2 DNA bands (Figure 3).
3.4. PCR for clinical samples
Optimized PCR reaction was done on 39 samples
from patients with brucellosis and 25 healthy people.
Intriguingly, the PCR reactions correctly developed a 233
bp DNA band for all samples from patients, while the
healthy samples only had the 684 bp band for IC. This
means that the PCR reaction is able to detect the Brucella
spp. with high accuracy.
4. Discussion
Brucella spp. are currently detected by microbiological
methods of bacterial culture from various biological
samples, serological methods of detecting anti-Brucella
antibodies, and molecular methods of detecting Brucella
DNA. Microbiological methods are based on cultures
from blood, tissue, and body fluids which suffer from low
sensitivity (15%–70%), long incubation period, and a risk
of laboratory-acquired infections (20). On the other hand,
serological methods could fail in early disease detection due
to their low sensitivity, possible serological cross-reactions,
and inability to differentiate between the antibodies from
an ongoing infection and persisting antibodies after
therapy (21). However, PCR-based methods of Brucella
spp. detection provide a sensitive and specific way for fast

Table 1. Primer pairs for internal control (IC) and Brucella polymerase chain reaction
(PCR) process along with their product sizes.
Name of primer

Sequence of primer

Product size

Brucella froward

CGAAGCCGTTGAATATGTCC

Brucella reverse

GTTCGGTGAAGGTCTTGAGG

IC froward

AGCATTCAAATCCTTCATACTG

IC reverse

ATGTTGGTGTAATCTGACTCG

233 bp
684 bp

Table 2. The volumes of samples employed for PCR are listed for single and coreactions.
Component

Volume for IC

Volume for Brucella

Volume for coreactions

Conc.

Taq 2X master mix

25 µL

25 µL

25 µL

1X

Primer F

1 µL

1 µL

1 µL

200 nM

Primer R

1 µL

1 µL

1 µL

200nM

Distilled water

21 µL

18 µL

16 µL

----

IC DNA

2 µL

-

2 µL

200 ng

Brucella DNA

-

5 µL

5 µL

200 ng

Total Volume

50 µL

50 µL

50 µL

----
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Figure 3. Coreaction of Brucella and internal control (IC)
primers. Lane 1 is 100 bp DNA ladder, lanes 2 and 3 are PCR
products of two positive clinical samples before optimization,
lanes 4 and 5 are PCR products of the same samples after
optimization. The 233 bp band appeared after optimization of
coreaction PCR conditions.

and accurate identification of this pathogen (7). In this
regard, we have developed a PCR based method to detect
Brucella species. Fekete et al. were the first to introduce a
PCR-based test for detection of brucellosis (22). Their PCR
reaction was based on the amplification a 635 bp fragment
(outer membrane protein gene) from B. abortus strain 19.
To the best of our knowledge, more than 200 studies have
been conducted employing various PCR based methods
to develop a useful tool for rapid brucellosis diagnosis.
Various PCR-based methods including standard PCR,
real-time PCR, multiplex PCR, nested and seminested
PCR, and other PCR-based assays have already been
exploited for detection of Brucella spp. (23). The attained
progresses in PCR techniques provide a suitable means for
specific identification of the infectious agents. However,
there is no standard setting for proper molecular screening
of Brucella infection. It should be noted that blood samples
for PCR detection are vulnerable because of possible
polymerase inhibitors like hemoglobin and human DNA
of white blood cells (WBC) and the reaction conditions
should be finely tuned for accurate detection. Although
several factors have been reported to affect the PCR results
for detection of Brucella spp., the efficiency of standard
PCR tests mainly depend on specificity of the designed
primers.
The Omp2 gene is one of the highly preferred targets
for PCR-based detection of Brucella species. Omp proteins
are bacterial membrane porins which control osmotic
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pressure of bacterium. Fiche et al. (1994) discovered this
gene and its polymorphisms for the first time (24). This
locus contains two similar genes, Omp2a and Omp2b,
which are separated with a 1900 bp fragment. B. aburtus
has a 108 bp deletion in bioware 1 and 2, while B. ovis
possesses two copies of Omp2a. Brucella isolates from
aquatic mammalians lack Omp2b but has two copies of
Omp2a (25). However, polymorphisms are often located at
3’ end of genes which makes 5’ end suitable for targeting.
In 1995, Leal et al. targeted Omp2 gene with specific
primers and it was proved to be more accurate than
serologic tests for blood and milk samples of goats (26).
This gene is reported to have a head-to-head duplication of
open reading frame with 85% homology (27). Therefore,
targeting this gene for PCR-based detection could result
in two times the normal amount of DNA amplification.
This property could be attained designing specific primers
for conserved regions of these genes. The Omp2 locus
of Brucella species and strains was reported to exhibit
the highest degree of polymorphism (28). Baddour et
al. reported that, among the three pairs of the evaluated
primers, the primer pair for amplification of Omp2 gene is
associated with the low sensitivity for detection of Brucella
spp. from human blood samples (29). We believe that low
sensitivity of Omp2-based detection of Brucella spp. could
be rooted in the high polymorphism rate of this genomic
location. However, this issue could be circumvented
via designing specific primers for the regions of Omp
locus with highest conservancy and highest coverage for
sequences from all Brucella species. Such a primer pair
could amplify the sequences with polymorphism and the
newly characterized sequences. Performing a multiple
sequence alignment for a large number of Omp sequences
(including sequences with different polymorphisms and
newly introduced sequences) is a prerequisite for such
primer design. In this regard, based on multiple sequence
alignment of 500 different Omp genes from Brucella spp.,
an important region of Omp2 gene (with highly conserved
regions) was identified within the gene sequence. Our
results for Omp2 gene proved equal or better accuracy
compared to other molecular techniques for rapid
detection of suspicious samples. Two-step PCR was
utilized for accurate identification of mentioned specific
sites. Some other studies are available with high accuracy
and lower specificity based on rDNA of Brucella (7,30).
Moreover, other PCR techniques such as nested PCR of
fragments between 16S and 23S can improve the obtained
results (31).
In conclusion, it should be noted that PCR-based
techniques could provide the healthcare professionals with
more accurate information about the Brucella infection.
Our setting could circumvent the drawbacks associated
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with conventional serum-based Brucella detection
methods. Moreover, due to inclusion of various Omp2
sequences, the sensitivity of the designed PCR test would
be higher than the previously described tests. Although,

this gene could be analyzed with more accurate PCR
hybrid techniques such as Loop-mediated Isothermal
Amplification (LAMP), the higher cost of these methods
makes our PCR-based approach more reasonable.
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